SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹9.85 Cr | ₹39 Cr | ₹-1.09 Cr | ₹-0.66 Cr | ₹-0.21 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹9.85 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹-1.09 Cr |
Mar2021 | ₹-0.66 Cr |
Mar2020 | ₹-0.21 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹9.85 Cr | -74.52 | |
Mar2023 | ₹39 Cr | Positive | |
Mar2022 | ₹-1.09 Cr | Negative | |
Mar2021 | ₹-0.66 Cr | Negative | |
Mar2020 | ₹-0.21 Cr | - |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹869.5 Cr | -4.9% | -2.9% | 1.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,098.0 Cr | 0.4% | -2.6% | 36% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,194.0 Cr | -0% | 3% | 54.9% | Stock Analytics | |
CIPLA | ₹116,773.0 Cr | -0.2% | -4% | 10.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,646.0 Cr | -2.6% | -1.8% | 13.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,125.0 Cr | -0.6% | 1% | 40.8% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -4.9% |
-2.9% |
1.9% |
SENSEX | 1% |
-3.9% |
5.1% |
You may also like the below Video Courses